# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-096178
Filing Date
2023-12-15
Accepted
2023-12-15 17:22:11
Documents
5
Period of Report
2023-12-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | pre14a1123_abvcbio.htm | PRE 14A | 9972835
2 | GRAPHIC | tflowchart_001.jpg | GRAPHIC | 342637
3 | GRAPHIC | twwc_footer.jpg | GRAPHIC | 76830
4 | GRAPHIC | twwc_header.jpg | GRAPHIC | 113423
5 | GRAPHIC | twwc_sign.jpg | GRAPHIC | 11546
| Complete submission text file | 0001213900-23-096178.txt |  | 10724507

Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40700 | Film No.: 231491426
SIC: 2834 Pharmaceutical Preparations